Business Wire

SERI Lugano Launches International Scientific Outreach Initiative on Light-Based Neuroscience and Pineal Gland Research

18.5.2026 15:38:00 CEST | Business Wire | Press release

Share

Researchers and clinicians from Switzerland expand interdisciplinary communication efforts integrating neuroscience, photobiomodulation, infrasound, and nutraceutical research

As scientific interest in light-based stimulation, neuroendocrine regulation, and integrative medicine continues to grow internationally, the Switzerland Eye Research Institute (SERI Lugano) has launched a new international scientific outreach initiative focused on public engagement and interdisciplinary research communication in neuroscience and cellular modulation.

This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20260515840289/en/

Ophthalmologist Roberto Pinelli explains, in an engaging personal narrative style, his unique methods for using a combination of light, sound, and nutraceuticals to non-invasively activate the pineal gland to promote cellular reju­venation, decrease aging, and improve overall well-being. Supported by case studies and peer-reviewed research, Pinelli’s method centers on using photons to convey vibrational energy through the eyes to target areas of the body with the sinergic use of sound vibrations and specific nutraceuticals. He shows the potent effects this has on overall wellbeing and mental health as it can improve memory, mental clarity, and self-awareness. His techniques also have positive effects on the body such as helping to heal degenerative diseases like AMD, retinal degenerations, Alzheimer’s, rheumatoid arthritis, and Parkinson’s.

The initiative aims to promote broader understanding of emerging research involving photobiomodulation, circadian biology, neuroendocrine processes, and the interaction between light, sound frequencies, and cellular function.

As part of this initiative, SERI Lugano is supporting the international publication and distribution of Awakening the Pineal Gland – Cellular Rejuvenation through Light and Sound, a new volume written by SERI Lugano founder and director Roberto Pinelli and published in the United States by Inner Traditions.

The pineal gland, a neuroendocrine structure historically associated with circadian regulation and melatonin production, has increasingly become an area of scientific interest in studies exploring the relationship between light exposure, brain activity, metabolism, and cellular signaling. Recent developments in neuroscience and photobiomodulation research have contributed to renewed attention toward the biological role of light in human physiology.

Photobiomodulation — a treatment that delivers intermittent low-frequency light through the pupillary foramen with the aim of modulating specific cellular functions — represents one of the areas explored within the initiative, together with infrasound stimulation and nutraceutical support strategies.

Researchers and clinicians affiliated with SERI Lugano are currently investigating the interaction between light-based stimulation, mitochondrial activity, circadian mechanisms, and neuroendocrine regulation, with particular attention to potential applications in integrative and regenerative medicine (Pinelli R. et al, “Combined pulses of light and sound in the retina with nutraceuticals may enhance the recovery of foveal holes”. Archives Italiennes de Biologie, 160: 3-21, 2022).

The initiative also promotes interdisciplinary dialogue between contemporary scientific investigation and historical perspectives on light and consciousness found in ancient civilizations, including Egyptian and Sumerian traditions. According to SERI Lugano, revisiting historical interpretations of human physiology may contribute to broader cultural reflection alongside modern scientific research.

“Scientific communication should help create bridges between advanced research, clinical observation, and public understanding,” said Roberto Pinelli, founder and director of SERI Lugano. “Our goal is to encourage interdisciplinary dialogue around the role of light, neuroscience, and cellular function in human physiology.”

The initiative reflects SERI Lugano’s broader commitment to integrating ophthalmology, neuroscience, photobiomodulation, and cellular research within an international scientific and educational framework.

The volume Awakening the Pineal Gland is distributed in the United States by Simon & Schuster and is available through major international platforms, including Amazon.com.

About Switzerland Eye Research Institute (SERI Lugano)

The Switzerland Eye Research Institute (SERI Lugano), based in Lugano, Switzerland, is an independent research and clinical institute focused on ophthalmology, neuroscience, photobiomodulation, and interdisciplinary research involving light-based technologies, neuroendocrine regulation, and cellular function.

The institute promotes integrative approaches combining clinical activity, scientific research, and public scientific communication.

Learn more:
www.seri-lugano.ch

View source version on businesswire.com: https://www.businesswire.com/news/home/20260515840289/en/

Subscribe to releases from Business Wire

Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.

Latest releases from Business Wire

Novotech Strengthens Presence in Japan with Opening of Tokyo Office24.8.2026 01:01:00 CEST | Press release

Novotech, a leading global biotech CRO and full-service clinical research organization, has strengthened its established presence in Japan with the opening of a new office in Tokyo. The investment builds on Novotech’s existing operations and clinical trial activity in Japan and further enhances its ability to support Japanese biopharma companies as they advance programs regionally and across key international markets. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20260823592174/en/ Takeshi Mori, Novotech Country Head, Japan The Tokyo office will serve as a strategic hub for Novotech’s growing operations in Japan, providing enhanced local expertise and strengthening collaboration with clients, partners, research institutions, and innovation ecosystems across the region. Novotech is currently supporting ongoing studies in Japan and provides sponsors with integrated support across early-phase clinical development in Australia, F

FDA Authorizes ZYN ULTRA Nicotine Pouches Following Scientific Review21.8.2026 21:11:00 CEST | Press release

Authorizations add selection of ZYN ULTRA products to PMI U.S.’s growing portfolio of better alternatives for legal-age adults who smoke or use traditional oral tobacco products Philip Morris International Inc. (NYSE: PM) today announces that the U.S. Food and Drug Administration (FDA) issued Marketing Granted Orders to PMI’s U.S. affiliate, Swedish Match USA, Inc., authorizing the marketing of 11 ZYN ULTRA moist oral nicotine pouch products, including all 9mg variants and one 11mg variant. Additional 11mg variants remain under scientific review. Today’s action further enhances PMI’s leadership role in the smoke-free category. “We are delighted with the FDA’s decision to authorize a range of ZYN ULTRA products, which will build on ZYN’s position as America’s leading smoke-free product brand,” said Stacey Kennedy, PMI U.S. CEO. “We look forward to expanding our portfolio of better choices for the 45 million Americans who consume nicotine products.” ZYN ULTRA positions the brand to furth

58% of Consumers Say They Don't Care Whether a Product is a National Brand or Private Label. They Just Buy What They Need21.8.2026 12:00:00 CEST | Press release

New NIQ & World Data Lab report reveals how consumer polarization is redefining value, accelerating private label adoption, and reshaping competition on the shelf As fast-moving consumer goods (FMCG) prices rose 26% globally between 2021 and 2025, consumers have become more deliberate about where they save and where they spend. NielsenIQ (NYSE: NIQ) has released new findings showing that private label is no longer viewed simply as a lower-cost substitute, but as a credible competitor across value, mainstream, and premium segments. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20260819950224/en/ Private label is no longer just a value play. The findings, published in NIQ’s latest report, A Tale of Two Consumers: The Polarized Mindsets Reshaping Global Consumption, created in collaboration with World Data Lab, show how consumer polarization is redefining value and reshaping competition on the shelf. The report also draws on ins

Tanium Reappoints Co-Founder Orion Hindawi as CEO to Drive Next Chapter of Growth20.8.2026 21:10:00 CEST | Press release

Company to focus on deepening its Autonomous IT capabilities, further expanding AI offerings across its portfolio, and strengthening customer and partner engagement Tanium, a leader in Autonomous IT, today announced that Co-Founder and Executive Chairman Orion Hindawi has been appointed Chief Executive Officer, effective immediately. Dan Streetman is stepping down as CEO and as a member of the Board after leading Tanium for the last three years, during which time Tanium scaled its go-to-market operations and secured strong industry analyst recognition for innovation within the Tanium platform. Streetman will continue to advise Tanium as part of the transition and co-founder David Hindawi will return to the role of Chairman of the Board. With this foundation in place, this transition positions Tanium to deepen its Autonomous IT capabilities and further expand AI offerings across its portfolio and strengthen customer and partner engagement. The Hindawis co-founded Tanium in 2007 to build

PCI Energy Solutions to Join Mitsubishi Electric, Reinforcing Long-Term Commitment to Customers, Employees, and the Energy Industry20.8.2026 19:46:00 CEST | Press release

Mitsubishi Electric to retain PCI’s core management team and support continuity of operations, customer service, and product innovation PCI Energy Solutions ("PCI"), a leading U.S.-based provider of enterprise software for energy management and optimization, announced today that it has entered into a definitive agreement to be acquired by Mitsubishi Electric Corporation. The agreement was executed on August 20, 2026 (Japan Standard Time). The Transaction represents a strong endorsement of PCI's business, technology, employees, customer relationships and position in the energy industry. Mitsubishi Electric intends to retain PCI's core management team following completion of the Transaction, enabling PCI to preserve leadership continuity, industry expertise and its customer-focused operating model while benefiting from Mitsubishi Electric's global scale, complementary capabilities and long-term investment capacity. The agreement has been signed, but the Transaction has not yet closed. PC

In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.

Visit our pressroom
World GlobeA line styled icon from Orion Icon Library.HiddenA line styled icon from Orion Icon Library.Eye